aluates Reports

$ 0.0

Automative

Global Small Interfering RNA (siRNA) Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-24Q16308

Global Small Interfering RNA siRNA Therapeutics Market Research Report 2024

BUY CHAPTERS

Global Small Interfering RNA (siRNA) Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-24Q16308

Report

December 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Horizon Discovery

Thermo Scientific

OPKO Health

AInylam Pharmaceuticals

Arrowhead Research

Sanofi Genzyme

Genecon Biotechnologies

Arbutus Biopharma

Silent Therapeutics

Sylentis

Small Interfering RNA (siRNA) Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Small Interfering RNA (siRNA) Therapeutics Market

Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It's also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell's own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.

Market Analysis and Insights: Global Small Interfering RNA (siRNA) Therapeutics Market

The global Small Interfering RNA (siRNA) Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Small Interfering RNA (siRNA) Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Small Interfering RNA (siRNA) Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Small Interfering RNA (siRNA) Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Small Interfering RNA (siRNA) Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Small Interfering RNA (siRNA) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Small Interfering RNA (siRNA) Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Small Interfering RNA (siRNA) Therapeutics Market Report

Report Metric	Details
Report Name	Small Interfering RNA (siRNA) Therapeutics Market
CAGR	5%
Segment by Type	Liposome Based Systemic Therapy Nanoparticle Based Systemic Therapy Other
Segment by Application	Hospital Research Institutions Pharmaceutical and Biotechnology Companies Academic Institutions Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Small Interfering RNA (siRNA) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Interfering RNA (siRNA) Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Small Interfering RNA (siRNA) Therapeutics Market report?

Ans: The main players in the Small Interfering RNA (siRNA) Therapeutics Market are GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis

What are the Application segmentation covered in the Small Interfering RNA (siRNA) Therapeutics Market report?

Ans: The Applications covered in the Small Interfering RNA (siRNA) Therapeutics Market report are Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other

What are the Type segmentation covered in the Small Interfering RNA (siRNA) Therapeutics Market report?

Ans: The Types covered in the Small Interfering RNA (siRNA) Therapeutics Market report are Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other

Recommended Reports

RNAi & siRNA Therapeutics

Oligonucleotides & Nucleic Acids

Gene & RNA Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Liposome Based Systemic Therapy

1.2.3 Nanoparticle Based Systemic Therapy

1.2.4 Other

1.3 Market by Application

1.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Research Institutions

1.3.4 Pharmaceutical and Biotechnology Companies

1.3.5 Academic Institutions

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Perspective (2019-2030)

2.2 Global Small Interfering RNA (siRNA) Therapeutics Growth Trends by Region

2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Small Interfering RNA (siRNA) Therapeutics Market Dynamics

2.3.1 Small Interfering RNA (siRNA) Therapeutics Industry Trends

2.3.2 Small Interfering RNA (siRNA) Therapeutics Market Drivers

2.3.3 Small Interfering RNA (siRNA) Therapeutics Market Challenges

2.3.4 Small Interfering RNA (siRNA) Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Small Interfering RNA (siRNA) Therapeutics by Players

3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Small Interfering RNA (siRNA) Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio

3.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Therapeutics Revenue in 2023

3.5 Global Key Players of Small Interfering RNA (siRNA) Therapeutics Head office and Area Served

3.6 Global Key Players of Small Interfering RNA (siRNA) Therapeutics, Product and Application

3.7 Global Key Players of Small Interfering RNA (siRNA) Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Type

4.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2025-2030)

5 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Application

5.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2019-2030)

6.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type

6.2.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application

6.3.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

6.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country

6.4.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2019-2030)

7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type

7.2.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application

7.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

7.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country

7.4.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2019-2030)

8.2 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type

8.2.1 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024)

8.2.2 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030)

8.2.3 China Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

8.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application

8.3.1 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024)

8.3.2 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030)

8.3.3 China Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2019-2030)

9.2 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type

9.2.1 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

9.3 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application

9.3.1 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

9.4 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Region

9.4.1 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GE

11.1.1 GE Company Details

11.1.2 GE Business Overview

11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction

11.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.1.5 GE Recent Developments

11.2 Horizon Discovery

11.2.1 Horizon Discovery Company Details

11.2.2 Horizon Discovery Business Overview

11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction

11.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.2.5 Horizon Discovery Recent Developments

11.3 Thermo Scientific

11.3.1 Thermo Scientific Company Details

11.3.2 Thermo Scientific Business Overview

11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction

11.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.3.5 Thermo Scientific Recent Developments

11.4 OPKO Health

11.4.1 OPKO Health Company Details

11.4.2 OPKO Health Business Overview

11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction

11.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.4.5 OPKO Health Recent Developments

11.5 AInylam Pharmaceuticals

11.5.1 AInylam Pharmaceuticals Company Details

11.5.2 AInylam Pharmaceuticals Business Overview

11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction

11.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.5.5 AInylam Pharmaceuticals Recent Developments

11.6 Arrowhead Research

11.6.1 Arrowhead Research Company Details

11.6.2 Arrowhead Research Business Overview

11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction

11.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.6.5 Arrowhead Research Recent Developments

11.7 Sanofi Genzyme

11.7.1 Sanofi Genzyme Company Details

11.7.2 Sanofi Genzyme Business Overview

11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction

11.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.7.5 Sanofi Genzyme Recent Developments

11.8 Genecon Biotechnologies

11.8.1 Genecon Biotechnologies Company Details

11.8.2 Genecon Biotechnologies Business Overview

11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction

11.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.8.5 Genecon Biotechnologies Recent Developments

11.9 Arbutus Biopharma

11.9.1 Arbutus Biopharma Company Details

11.9.2 Arbutus Biopharma Business Overview

11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction

11.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.9.5 Arbutus Biopharma Recent Developments

11.10 Silent Therapeutics

11.10.1 Silent Therapeutics Company Details

11.10.2 Silent Therapeutics Business Overview

11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction

11.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.10.5 Silent Therapeutics Recent Developments

11.11 Sylentis

11.11.1 Sylentis Company Details

11.11.2 Sylentis Business Overview

11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction

11.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

11.11.5 Sylentis Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Horizon Discovery

Thermo Scientific

OPKO Health

AInylam Pharmaceuticals

Arrowhead Research

Sanofi Genzyme

Genecon Biotechnologies

Arbutus Biopharma

Silent Therapeutics

Sylentis

List of Tables

Table 1. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Liposome Based Systemic Therapy

Table 3. Key Players of Nanoparticle Based Systemic Therapy

Table 4. Key Players of Other

Table 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Region (2019-2024)

Table 9. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Region (2025-2030)

Table 11. Small Interfering RNA (siRNA) Therapeutics Market Trends

Table 12. Small Interfering RNA (siRNA) Therapeutics Market Drivers

Table 13. Small Interfering RNA (siRNA) Therapeutics Market Challenges

Table 14. Small Interfering RNA (siRNA) Therapeutics Market Restraints

Table 15. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top Small Interfering RNA (siRNA) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2023)

Table 18. Global Small Interfering RNA (siRNA) Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Small Interfering RNA (siRNA) Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Small Interfering RNA (siRNA) Therapeutics, Product and Application

Table 22. Global Key Players of Small Interfering RNA (siRNA) Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Small Interfering RNA (siRNA) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Small Interfering RNA (siRNA) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Small Interfering RNA (siRNA) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. GE Company Details

Table 65. GE Business Overview

Table 66. GE Small Interfering RNA (siRNA) Therapeutics Product

Table 67. GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 68. GE Recent Developments

Table 69. Horizon Discovery Company Details

Table 70. Horizon Discovery Business Overview

Table 71. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product

Table 72. Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Horizon Discovery Recent Developments

Table 74. Thermo Scientific Company Details

Table 75. Thermo Scientific Business Overview

Table 76. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product

Table 77. Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Thermo Scientific Recent Developments

Table 79. OPKO Health Company Details

Table 80. OPKO Health Business Overview

Table 81. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product

Table 82. OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 83. OPKO Health Recent Developments

Table 84. AInylam Pharmaceuticals Company Details

Table 85. AInylam Pharmaceuticals Business Overview

Table 86. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product

Table 87. AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 88. AInylam Pharmaceuticals Recent Developments

Table 89. Arrowhead Research Company Details

Table 90. Arrowhead Research Business Overview

Table 91. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product

Table 92. Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Arrowhead Research Recent Developments

Table 94. Sanofi Genzyme Company Details

Table 95. Sanofi Genzyme Business Overview

Table 96. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product

Table 97. Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Sanofi Genzyme Recent Developments

Table 99. Genecon Biotechnologies Company Details

Table 100. Genecon Biotechnologies Business Overview

Table 101. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product

Table 102. Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Genecon Biotechnologies Recent Developments

Table 104. Arbutus Biopharma Company Details

Table 105. Arbutus Biopharma Business Overview

Table 106. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product

Table 107. Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Arbutus Biopharma Recent Developments

Table 109. Silent Therapeutics Company Details

Table 110. Silent Therapeutics Business Overview

Table 111. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product

Table 112. Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 113. Silent Therapeutics Recent Developments

Table 114. Sylentis Company Details

Table 115. Sylentis Business Overview

Table 116. Sylentis Small Interfering RNA (siRNA) Therapeutics Product

Table 117. Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024) & (US$ Million)

Table 118. Sylentis Recent Developments

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Liposome Based Systemic Therapy Features

Figure 4. Nanoparticle Based Systemic Therapy Features

Figure 5. Other Features

Figure 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Research Institutions Case Studies

Figure 10. Pharmaceutical and Biotechnology Companies Case Studies

Figure 11. Academic Institutions Case Studies

Figure 12. Other Case Studies

Figure 13. Small Interfering RNA (siRNA) Therapeutics Report Years Considered

Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Region: 2023 VS 2030

Figure 17. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players in 2023

Figure 18. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue in 2023

Figure 20. North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

Figure 22. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

Figure 23. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2019-2030)

Figure 24. United States Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

Figure 28. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

Figure 29. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2019-2030)

Figure 30. Germany Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Small Interfering RNA (siRNA) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

Figure 38. China Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Small Interfering RNA (siRNA) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

Figure 41. Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

Figure 42. Asia Small Interfering RNA (siRNA) Therapeutics Market Share by Region (2019-2030)

Figure 43. Japan Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2019-2030)

Figure 53. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GE Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 60. Horizon Discovery Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 61. Thermo Scientific Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 62. OPKO Health Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 63. AInylam Pharmaceuticals Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 64. Arrowhead Research Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 65. Sanofi Genzyme Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 66. Genecon Biotechnologies Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 67. Arbutus Biopharma Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 68. Silent Therapeutics Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 69. Sylentis Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global RNAi Therapeutics Market Research Report 2024

Global Small Interfering RNA siRNA Market Research Report 2024

Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

RNAi Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vector Based RNAi Market Research Report 2024

Global siRNA Drug Market Research Report 2024

Global Nucleic Acid Drugs Market Research Report 2025

Global Small Nucleic Acid Drug Market Research Report 2025

Global RNA Therapeutics Market Research Report 2024

RNAi Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antisense and RNA Interference Therapeutics Market Research Report 2024

Global siRNA Drugs Market Research Report 2024

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Global RNA Interference RNAi Drug Delivery Market Research Report 2025

Global RNA Vaccines Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions